Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis
- 1 January 1987
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 92 (1) , 60-67
- https://doi.org/10.1016/0016-5085(87)90840-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreasGastroenterology, 1986
- New carbohydrate tumor markersGastroenterology, 1986
- Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumorCancer, 1985
- Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.Gut, 1985
- Carbohydrate Antigenic Determinant (CA 19–9) and Other Tumor Markers in Gastrointestinal MalignanciesDigestion, 1985
- Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bankInternational Journal of Cancer, 1984
- Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.Journal of Clinical Pathology, 1984
- Specific Antigen in Serum of Patients with Colon CarcinomaScience, 1981
- A Monosialoganglioside Is a Monoclonal Antibody-Defined Antigen of Colon CarcinomaScience, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979